Mangoceuticals Inc (NASDAQ: MGRX)’s stock price has dropped by -10.20 in relation to previous closing price of 0.24. Nevertheless, the company has seen a loss of -8.67% in its stock price over the last five trading days. globenewswire.com reported 2024-10-03 that Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, announces the release of its latest innovation, “TRIM,” a compounded, oral dissolvable Tirzepatide tablet. Available for purchase at $399 per month, this new product offers patients an advanced and convenient alternative to injectable therapies.
Is It Worth Investing in Mangoceuticals Inc (NASDAQ: MGRX) Right Now?
Company’s 36-month beta value is 1.62.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MGRX is 19.06M, and currently, short sellers hold a 1.07% ratio of that floaft. The average trading volume of MGRX on October 07, 2024 was 4.19M shares.
MGRX’s Market Performance
MGRX’s stock has seen a -8.67% decrease for the week, with a -18.97% drop in the past month and a -38.46% fall in the past quarter. The volatility ratio for the week is 33.71%, and the volatility levels for the past 30 days are at 14.46% for Mangoceuticals Inc The simple moving average for the past 20 days is -14.30% for MGRX’s stock, with a -25.93% simple moving average for the past 200 days.
MGRX Trading at -25.85% from the 50-Day Moving Average
After a stumble in the market that brought MGRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.44% of loss for the given period.
Volatility was left at 14.46%, however, over the last 30 days, the volatility rate increased by 33.71%, as shares sank -18.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -47.83% lower at present.
During the last 5 trading sessions, MGRX fell by -8.67%, which changed the moving average for the period of 200-days by -21.22% in comparison to the 20-day moving average, which settled at $0.2532. In addition, Mangoceuticals Inc saw -20.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MGRX starting from Hamilton Alex P., who sale 108,426 shares at the price of $0.32 back on Jun 26 ’24. After this action, Hamilton Alex P. now owns 50,000 shares of Mangoceuticals Inc, valued at $34,696 using the latest closing price.
Hamilton Alex P., the Director of Mangoceuticals Inc, sale 16,574 shares at $0.31 during a trade that took place back on Jun 25 ’24, which means that Hamilton Alex P. is holding 158,426 shares at $5,138 based on the most recent closing price.
Stock Fundamentals for MGRX
Current profitability levels for the company are sitting at:
- -10.27 for the present operating margin
- 0.58 for the gross margin
The net margin for Mangoceuticals Inc stands at -10.53. The total capital return value is set at -0.6. Equity return is now at value -102.35, with -93.44 for asset returns.
Based on Mangoceuticals Inc (MGRX), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -20.97. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -40.3.
Currently, EBITDA for the company is -9.19 million with net debt to EBITDA at 0.02. When we switch over and look at the enterprise to sales, we see a ratio of 7.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.38.
Conclusion
In a nutshell, Mangoceuticals Inc (MGRX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
